Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

D. Bengtsson; H. D. Schrøder; K. Berinder; D. Maiter; C. Hoybye; O. Ragnarsson; U. Feldt-Rasmussen; Å. Krogh Rasmussen; A. van der Lely; M. Petersson; G. Johannsson; M. Andersen; P. Burman

doi:10.1007/s12020-018-1751-9

Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

D. Bengtsson, H. D. Schrøder, K. Berinder, D. Maiter, C. Hoybye, O. Ragnarsson, U. Feldt-Rasmussen, Å. Krogh Rasmussen, A. van der Lely, M. Petersson, G. Johannsson, M. Andersen, P. Burman

Genomik, diabetes och endokrinologi

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Sidor (från-till)	737-739
Tidskrift	Endocrine
Volym	62
Nummer	3
Tidigt onlinedatum	2018 sep. 24
DOI	https://doi.org/10.1007/s12020-018-1751-9
Status	Published - 2018

Ämnesklassifikation (UKÄ)

Endokrinologi och diabetes

Tillgång till dokument

10.1007/s12020-018-1751-9

Citera det här

Bengtsson, D., Schrøder, H. D., Berinder, K., Maiter, D., Hoybye, C., Ragnarsson, O., Feldt-Rasmussen, U., Krogh Rasmussen, Å., van der Lely, A., Petersson, M., Johannsson, G., Andersen, M., & Burman, P. (2018). Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide. Endocrine, 62(3), 737-739. https://doi.org/10.1007/s12020-018-1751-9

@article{1d38974cc83545ee8c2556635ade072f,

title = "Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide",

author = "D. Bengtsson and Schr{\o}der, {H. D.} and K. Berinder and D. Maiter and C. Hoybye and O. Ragnarsson and U. Feldt-Rasmussen and {Krogh Rasmussen}, {\AA}. and {van der Lely}, A. and M. Petersson and G. Johannsson and M. Andersen and P. Burman",

year = "2018",

doi = "10.1007/s12020-018-1751-9",

language = "English",

volume = "62",

pages = "737--739",

journal = "Endocrine",

issn = "1355-008X",

publisher = "Humana Press",

number = "3",

}

Bengtsson, D, Schrøder, HD, Berinder, K, Maiter, D, Hoybye, C, Ragnarsson, O, Feldt-Rasmussen, U, Krogh Rasmussen, Å, van der Lely, A, Petersson, M, Johannsson, G, Andersen, M & Burman, P 2018, 'Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide', Endocrine, vol. 62, nr. 3, s. 737-739. https://doi.org/10.1007/s12020-018-1751-9

TY - JOUR

T1 - Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

AU - Bengtsson, D.

AU - Schrøder, H. D.

AU - Berinder, K.

AU - Maiter, D.

AU - Hoybye, C.

AU - Ragnarsson, O.

AU - Feldt-Rasmussen, U.

AU - Krogh Rasmussen, Å.

AU - van der Lely, A.

AU - Petersson, M.

AU - Johannsson, G.

AU - Andersen, M.

AU - Burman, P.

PY - 2018

Y1 - 2018

U2 - 10.1007/s12020-018-1751-9

DO - 10.1007/s12020-018-1751-9

M3 - Letter

C2 - 30246233

AN - SCOPUS:85053657322

SN - 1355-008X

VL - 62

SP - 737

EP - 739

JO - Endocrine

JF - Endocrine

IS - 3

ER -